Form 4: TransMedics Group Executive Sells Shares to Cover Tax Obligations

A TransMedics Group, Inc. executive sold a portion of their common stock to satisfy tax withholding obligations related to the vesting of restricted stock units.

Summary

• Anil P. Ranganath, Senior Vice President, General Counsel, and Secretary of TransMedics Group, Inc. (TMDX), reported a sale of common stock.
• The transaction occurred on June 9, 2025.
• A total of 686 shares of common stock were sold at a price of $139.8 per share.
• Following this transaction, Mr. Ranganath beneficially owns 13,955 shares of TransMedics Group, Inc. common stock.
• The sale was a "sell to cover" transaction, specifically executed to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs).

Sentiment

Score: 5

Explanation: The transaction is a routine 'sell to cover' for tax purposes following RSU vesting, which is a neutral event for company valuation and does not indicate positive or negative sentiment towards the company's prospects.

Positives

• The underlying event, the vesting of restricted stock units, represents a positive compensation event for the executive.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• "Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."
• "This sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction pursuant to the terms of the RSU award."

Industry Context

This filing reports a routine insider transaction (a 'sell to cover' sale) and does not provide information relevant to broader industry trends or competitive dynamics within the medical device or organ transplant technology sector.

Comparison to Industry Standards

• This document, being a routine insider transaction report, does not contain information suitable for comparison to global industry benchmarks, specific comparable companies, projects, or results.

Stakeholder Impact

• Shareholders: Minimal impact, as it's a routine, non-discretionary sale for tax purposes and does not signal a change in management's confidence.
• Employees: The vesting of RSUs is a standard part of executive compensation, indicating the fulfillment of equity incentives.

Key Dates

Keywords

TransMedics Group, TMDX, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Anil P. Ranganath, Beneficial Ownership